Your browser doesn't support javascript.
loading
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression.
Claiborne, Daniel T; Prince, Jessica L; Scully, Eileen; Macharia, Gladys; Micci, Luca; Lawson, Benton; Kopycinski, Jakub; Deymier, Martin J; Vanderford, Thomas H; Nganou-Makamdop, Krystelle; Ende, Zachary; Brooks, Kelsie; Tang, Jianming; Yu, Tianwei; Lakhi, Shabir; Kilembe, William; Silvestri, Guido; Douek, Daniel; Goepfert, Paul A; Price, Matthew A; Allen, Susan A; Paiardini, Mirko; Altfeld, Marcus; Gilmour, Jill; Hunter, Eric.
Afiliação
  • Claiborne DT; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Prince JL; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Scully E; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139;
  • Macharia G; Human Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom;
  • Micci L; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Lawson B; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Kopycinski J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom; Faculty of Medicine, Imperial College, London SW7 2AZ, United Kingdom;
  • Deymier MJ; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Vanderford TH; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Nganou-Makamdop K; Vaccine Research Center, National Institutes of Health, Bethesda, MD 20817;
  • Ende Z; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Brooks K; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Tang J; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294;
  • Yu T; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA 30322;
  • Lakhi S; Zambia-Emory HIV Research Project, Lusaka, Zambia;
  • Kilembe W; Zambia-Emory HIV Research Project, Lusaka, Zambia;
  • Silvestri G; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Douek D; Vaccine Research Center, National Institutes of Health, Bethesda, MD 20817;
  • Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294;
  • Price MA; Epidemiology Unit, International AIDS Vaccine Initiative, San Francisco, CA 94143; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143;
  • Allen SA; Zambia-Emory HIV Research Project, Lusaka, Zambia; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322; and.
  • Paiardini M; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329;
  • Altfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139; Virus Immunology Unit, Heinrich-Pette-Institut, 20251 Hamburg, Germany.
  • Gilmour J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London SW10 9NH, United Kingdom; Faculty of Medicine, Imperial College, London SW7 2AZ, United Kingdom;
  • Hunter E; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322; ehunte4@emory.edu.
Proc Natl Acad Sci U S A ; 112(12): E1480-9, 2015 Mar 24.
Article em En | MEDLINE | ID: mdl-25730868
ABSTRACT
HIV-1 infection is characterized by varying degrees of chronic immune activation and disruption of T-cell homeostasis, which impact the rate of disease progression. A deeper understanding of the factors that influence HIV-1-induced immunopathology and subsequent CD4(+) T-cell decline is critical to strategies aimed at controlling or eliminating the virus. In an analysis of 127 acutely infected Zambians, we demonstrate a dramatic and early impact of viral replicative capacity (vRC) on HIV-1 immunopathogenesis that is independent of viral load (VL). Individuals infected with high-RC viruses exhibit a distinct inflammatory cytokine profile as well as significantly elevated T-cell activation, proliferation, and CD8(+) T-cell exhaustion, during the earliest months of infection. Moreover, the vRC of the transmitted virus is positively correlated with the magnitude of viral burden in naive and central memory CD4(+) T-cell populations, raising the possibility that transmitted viral phenotypes may influence the size of the initial latent viral reservoir. Taken together, these findings support an unprecedented role for the replicative fitness of the founder virus, independent of host protective genes and VL, in influencing multiple facets of HIV-1-related immunopathology, and that a greater focus on this parameter could provide novel approaches to clinical interventions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Replicação Viral / Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Replicação Viral / Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2015 Tipo de documento: Article